NEULAND LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,095 INR | -0.05% |
|
+4.24% | +53.10% |
| Jul. 02 | Neuland Laboratories Leases Part of Telangana Property for INR315 Million | MT |
| May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 |
Chart calendar Neuland Laboratories Limited
5af5ef772d1.amE5-uyRybkoWWhgSsoqDOjEAF_bvyKBw9dTszQRHj4.Gg1Nko7UiMBHM1oEeZJZU7qcZmyZ51TisJkY2kZ5SFZZN1_L3_ms6h0gGw~02ba24d2fae42d9478ff6931dc7a75f8
Upcoming events on Neuland Laboratories Limited
Past events on Neuland Laboratories Limited
| 2024-07-11 | Détachement de for final dividend |
| 2024-06-24 | Non Deal Roadshow - Day 2 |
| 2024-06-23 | Non Deal Roadshow - Day 1 |
| 2024-06-10 | Goldman Sachs Investor Day |
| 2024-06-06 | Ambit Titans of Tomorrow Conference |
| 2024-06-02 | Nuvama India Conference |
| 2024-05-30 | Trinity India B&K Securities Conference |
| 2024-05-14 01:30 am | Q4 2024 Earnings Call |
| 2024-05-10 06:46 am | Q4 2024 Earnings Release |
| 2024-03-14 | Investor Meeting |
| 2024-03-06 | Investor Meeting - ICICI Securities Ltd. |
| 2024-02-09 06:30 am | Q3 2024 Earnings Call |
| 2024-02-08 06:30 am | Q3 2024 Earnings Release |
| 2023-12-06 | Investor Meeting - Invesco Mutual Fund, |
| 2023-11-07 | Investor Meeting - Anandrathi Institutional Equities |
| 2023-11-07 06:30 am | Q2 2024 Earnings Call |
| 2023-11-07 04:08 am | Q2 2024 Earnings Release |
| 2023-08-03 07:30 am | Q1 2024 Earnings Call |
| 2023-08-03 05:32 am | Q1 2024 Earnings Release |
| 2023-07-27 01:30 am | Annual General Meeting |
Past dividends on Neuland Laboratories Limited
| 2024-07-11 | Annual 14 INR |
| 2023-07-10 | Annual 10 INR |
| 2022-07-13 | Annual 5 INR |
| 2021-06-28 | Final Payment 3 INR |
| 2020-11-09 | Interim Payment 2 INR |
| 2020-02-17 | Interim Payment 2 INR |
| 2019-06-26 | Annual 1.2 INR |
| 2016-08-03 | Annual 2 INR |
| 2015-08-05 | Annual 1.5 INR |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 7 627 7 436 2.57% | 9 369 9 248 1.31% | 9 511 9 513 -0.02% | 11 912 10 295 15.71% | 15 586 15 825 -1.51% | 15 980 |
|
EBITDA Million INR | Released Forecast Spread | 1 019 938 8.59% | 1 468 1 571 -6.51% | 1 426 1 340 6.43% | 2 718 1 894 43.53% | 4 626 4 763 -2.87% | 4 272 |
|
EBIT Million INR | Released Forecast Spread | 706 592 19.27% | 1 071 1 221 -12.25% | 936 975 -3.97% | 0,00 0,00 - | 4 029 4 373 -7.86% | 3 856 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 529 477 10.95% | 1 053 1 047 0.61% | 822 894 -8.04% | 2 157 1 231 75.26% | 4 014 4 144 -3.13% | 4 023 |
|
Net income Million INR | Released Forecast Spread | 162 368 -55.99% | 806 800 0.79% | 638 681 -6.21% | 1 635 911 79.49% | 3 001 3 108 -3.45% | 3 017 |
|
EPS INR | Released Forecast Spread | 12,6 28,5 -55.74% | 62,9 63,5 -1.02% | 49,7 52,7 -5.62% | 127 78,8 61.74% | 234 241 -2.91% | 234 |
| Announcement Date | 22/05/20 | 11/05/21 | 10/05/22 | 11/05/23 | 10/05/24 | - |
Quarterly results
| Fiscal Period | Marzo | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 2 559 2 471 3.55% | 2 212 2 174 1.73% | 2 937 2 681 9.55% | 4 071 2 866 42.04% | 3 630 2 986 21.57% | 4 177 3 466 20.53% | 3 928 3 635 8.07% | 3 850 4 068 -5.36% | 3 778 | 3 922 | 3 978 | 3 782 |
|
EBITDA Million INR | Released Forecast Spread | 389 336 15.68% | 286 298 -4.01% | 693 416 66.78% | 1 199 593 102.12% | 969 739 31.15% | 1 375 884 55.53% | 1 213 1 040 16.6% | 1 069 1 175 -9.01% | ||||
|
EBIT Million INR | Released Forecast Spread | 905 1 026 -11.84% | 822 | 853 | 865 | 813 | |||||||
|
Net income Million INR | Released Forecast Spread | 218 133 63.76% | 99,7 119 -16.25% | 385 215 78.88% | 845 332 154.65% | 619 426 45.26% | 892 548 62.86% | 814 658 23.69% | 676 744 -9.19% | ||||
| Announcement Date | 10/05/22 | 03/08/22 | 10/11/22 | 11/05/23 | 03/08/23 | 07/11/23 | 08/02/24 | 10/05/24 | - | - | - | - |
| 2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
| 2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
| 2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
| 2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
| 2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
| 2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Neuland Laboratories Limited
| 2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
| 2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEULANDLAB Stock
- Calendar Neuland Laboratories Limited
